Xenon Pharmaceuticals XENE Burnaby British Columbia — Lessee Number Of Operating Leases
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept xene:LesseeNumberOfOperatingLeases.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's burnaby british columbia — lessee number of operating leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's burnaby british columbia — lessee number of operating leases?
- Xenon Pharmaceuticals (XENE) reported burnaby british columbia — lessee number of operating leases of 1 in Q1 2026.
- How has Xenon Pharmaceuticals's burnaby british columbia — lessee number of operating leases changed year-over-year?
- Xenon Pharmaceuticals's burnaby british columbia — lessee number of operating leases decreased by 0.0% year-over-year, from 1 to 1.
- What does burnaby british columbia — lessee number of operating leases mean?
- This metric represents the total count of active operating lease agreements held by the company within the specified geographic segment. It provides insight into the company's physical footprint and fixed operational commitments in that region. Monitoring this count helps investors assess the scale of facility-related obligations and the company's reliance on leased infrastructure for its clinical and administrative operations.